Glenmark And IADVL Undertake Awareness Campaign Supporting Vitiligo Patients In India

·         Glenmark released Picture Post Cards in collaboration with the Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL) Supporting Vitiligo Patients in India on World Vitiligo Day.

·         The picture postcards & Calendar featured the winning artworks from dermatologists from across the country.

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, integrated, global pharmaceutical company, has joined forces with The Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL), to unveil postcards & Calendars aimed at raising awareness, showing empathy and support for individuals living with vitiligo, a skin disorder that affects pigmentation.

In an effort to combat misinformation and promote acceptance, Glenmark and IADVL conducted a unique painting competition named “Empathy in Every Stroke” on World Vitiligo Day, June 25, 2024. The competition aimed to spotlight the significance of awareness, understanding, and treatment for vitiligo patients. Dermatologists from across the country participated, submitting over 150+ entries that creatively portrayed patients' journey with vitiligo and advocated for the importance of embracing diversity.

A panel of judges, including renowned creative maestro, gold medallist from Sir JJ School of Arts, Mr Uday Parkar & famous contemporary Indian artist, Ms Arpa Mukhopadhyay, meticulously reviewed the submissions to select the winning artworks.

22 winning paintings by the dermatologists from across India were selected in the process, 12 of which will be part of the IADVL calendar for the year 2025. 10 of these paintings have been transformed into captivating postcards that will serve as a constant reminder of the significance of empathy, acceptance, and respect for those affected by vitiligo.

Speaking on the occasion, Alok Malik, President and Business Head, India Formulations, Glenmark Pharmaceuticals Ltd. said, “We are proud to support our collaboration again with the Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL) in raising awareness for vitiligo. This initiative reflects our commitment to inclusivity and making a positive impact. Our painting competition inspired over 150+ entries from dermatologists, now featured on postcards & calendar. These cards symbolize our dedication to empathy, acceptance, and respect for those affected by vitiligo. We aim to challenge misconceptions and foster a more inclusive society, making a meaningful difference in the lives of vitiligo patients.”

Dr Manjunath Shenoy, President, IADVL said, "India has the highest prevalence of vitiligo in the world, and patients often face stigmatization and social isolation. We believe in the power of collective efforts to create awareness and acceptance for the same. These postcards & calendars are small but impactful steps towards supporting vitiligo patients and promoting a more inclusive society."

About vitiligo:

Vitiligo is a condition characterized by the loss of skin pigmentation due to the malfunction or destruction of melanin-producing cells, and impacts not only physical appearance but also psychological well-being. The latest data from the Indian Journal of Clinical and Experimental Dermatology 2022 indicates that the prevalence of Vitiligo ranges from 0.5 to 1 % Worldwide with a high prevalence of 8.8% in India.i Despite its prevalence and impact, vitiligo often remains misunderstood, leading to societal stigmatization and prejudice. India is home to the highest rate of vitiligo cases globally, with one in ten individuals being affected by the condition.

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. (BSE: 532296 | NSE: GLENMARK) is a research?led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. The company has 11 world-class manufacturing facilities spread across 4 continents, and operations in over 80 countries. In Vivo/Scrip 100 positions Glenmark amongst the Top 100 Companies Ranked by R&D and Pharmaceutical Sales, 2022; while Generics Bulletin/In Vivo places it in the Top 50 Generics and Biosimilars Companies Ranked by Sales, 2022. Glenmark’s Green House Gas (GHG) emission reduction targets have been approved in 2023 by the Science Based Target initiative (SBTi), making it only the second pharmaceutical company in India to achieve this. The organization has impacted more than 3 million lives over the last decade through its CSR interventions. For more information, visit www.glenmarkpharma.com. You can follow us on LinkedIn (Glenmark Pharmaceuticals) and Instagram (glenmark_pharma).

About IADVL:

The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL), the largest representing official society of Indian Dermatologists was established in its present form on 28th January, 1973. IADVL also happens to be the world’s 2nd largest Association of Dermatologists behind the American Academy of Dermatology. It is the national association of Indian medical specialists who manage patients with skin disorders, sexually transmitted infections (STIs) or leprosy. The current member strength of the association is 17,000+ members.